News

FDA approves Aurobindo’s generic Exelon

BY David Salazar
SILVER SPRING, Md. — Aurobindo Pharma announced Monday that it had received final approval from the Food and Drug Administration for its generic Exelon (rivastigmine tartrate) capsules. The drug is indicated to treat mild to moderate Alzheimer’s-related dementia, as well as mild to moderate dementia associated with Parkinson’s disease. 
 
The capsules will be available in 1.5-, 3-, 4.5-, and 6-mg dosage strengths. The drug had annual sales of about $26.2 million for the 12 months ended February 2016, according to IMS Health. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Consumers not rushing to Amazon Dash

BY Dan Berthiaume

Although Amazon.com recently more than tripled the number of items available via its Amazon Dash buttons and cited some impressive growth statistics, actual use may be relatively low.

According to daily analysis of a panel of more than 4 million online shoppers from digital commerce research firm Slice Intelligence, fewer than 50% of people who had bought a Dash button before Amazon expanded the assortment on March 31 had ever actually made an order using one.

According to Amazon, in the past three months, Dash button orders have grown by more than 75%, with customers using the buttons more than once a minute. Dash buttons are available to Prime members for $4.99 each, with a $4.99 credit after the first order.

Data from Slice Intelligence indicates that for Dash button purchases made prior to March 31, the average spend per order has varied between $10.76 and $27.11, with Bounty having the highest average spend. On average, Dash Button users order items about once every two months

Slice Intelligence analysis also shows that the typical Dash button buyer displays the stereotypical characteristics of a technology “early adopter” – male and affluent. According to Slice, as traditionally seen with early products, the buttons are only being purchased by a very small subset of the online shopping population. With the introduction of more brands, the buttons may be adopted by a larger set of consumers.

The top-selling button available to buyers is for Tide. The Tide SKU available is for the 81-count package of Tide laundry pods, priced at $19.97. The other CPG brands in the top 10-selling button list are Cottonelle, Bounty, Glad, Gatorade, Mrs. Meyer’s, Gillette, Smartwater, Ziploc and Huggies.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Walgreens study: Pharmacy interventions improve adherence, lower costs

BY David Salazar
DEERFIELD, Ill. — Walgreens on Monday released the results of a study that showed its pharmacy patients who used a multi-faceted medication adherence program had a 3% higher medication adherence rate and lower healthcare costs than those who use other pharmacies. The results were published in Population Health Management. 
 
The study looked at patients initiating therapy in 16 classes of drugs for common chronic conditions over the course of six months in 2013 and compared Walgreens patients to those at other pharmacies. It found that in addition to the 3% adherence boost, Walgreens patients w had 1.8% fewer hospital readmissions and 2.7% fewer emergency room visits. Additionally, on a per-patient basis, Walgreens’ intervention group saw lower pharmacy costs, outpatient costs and ER expenditures, as well as total health care costs over the course of the study — about a $226 savings overall. 
 
“This data quantifies the role our community pharmacy platform plays in achieving better population health outcomes,” study author and Walgreens senior director of health analytics, research and reporting Michael Taitel said. “These findings clearly illustrate that the combination of pharmacist counseling, medication therapy management, refill reminders and telephonic and digital pharmacy interventions, tailored to patients’ needs, drive better adherence. Further, this improvement in adherence results in fewer hospitalizations and emergency room visits, ultimately benefitting payers by lowering the overall cost of care.”
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?